Control-IQ Technology Linked to Improved Glycemic Control, Regardless of Patient Age

A meta-analysis of trials examining use of the t:slim X2 insulin pump with Control-IQ technology, results of the study indicate use of the hybrid closed loop technology was associated with improvements in glycemic control, regardless of patient age, race, or previous CGM use.

Related Keywords

Michigan ,United States ,Royw Beck ,Roy Beck ,Boris Kovatchev ,Health Research ,Drug Administration ,Technology In Youth ,Diabetes Technology ,University Of Virginia ,Jaeb Center ,Michigan Medicine ,Tandem Diabetes Care ,Randomized Trial Outcomes ,Diabetes Technol ,Published April ,Diabetes Care ,Published June ,